Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Share-based Compensation (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Share-based Compensation for 17 consecutive years, with -$685000.0 as the latest value for Q1 2026.

  • Quarterly Share-based Compensation fell 130.69% to -$685000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.8 million through Mar 2026, down 6.78% year-over-year, with the annual reading at $8.8 million for FY2025, 64.53% up from the prior year.
  • Share-based Compensation for Q1 2026 was -$685000.0 at Achieve Life Sciences, down from $1.3 million in the prior quarter.
  • The five-year high for Share-based Compensation was $2.9 million in Q2 2025, with the low at -$685000.0 in Q1 2026.
  • Average Share-based Compensation over 5 years is $1.2 million, with a median of $1.2 million recorded in 2023.
  • The sharpest move saw Share-based Compensation skyrocketed 12530.0% in 2024, then crashed 130.69% in 2026.
  • Achieve Life Sciences' Share-based Compensation stood at $778000.0 in 2022, then crashed by 101.29% to -$10000.0 in 2023, then skyrocketed by 12530.0% to $1.2 million in 2024, then increased by 4.67% to $1.3 million in 2025, then tumbled by 152.65% to -$685000.0 in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Share-based Compensation are -$685000.0 (Q1 2026), $1.3 million (Q4 2025), and $2.3 million (Q3 2025).